Research Services

Published on diagene gmbh (http://www.diagene.ch)

Basic Research Services

Single nucleotide analysis
Analysis of complex genetic diseases
Multivariate analysis
Population genetic models
Gene regulation studies

Clinical Research Services

Recruitment of probands and patients (phase 2 - 4)
Prospective, intervential studies on a large scale (single center,multicenter)
Coordination of multicenter studies
Laboratory analyses
Statistical analyses

Family Programs

Family tracing programs: early detection and early treatment prevents from complications in asymptomatic inherited diseases
- familial forms of hypercholesterolemia
- familial forms of cardiac arrhythmias
- familial forms of hypercoagulopathies

More information about research projects:
Monday - Saturday	24hrs, 7 days
Phone:	+41 79 708 66 17

Emergencies / technical questions:
Monday - Friday	24hrs, 7 days
Phone:	+41 79 708 66 17

Browse gene tests

by disease [1]
by gene [2]

Metabolism

Alström Disease (sequence of entire gene) [17]

Fabry's Disease (main mutations) [18]

Fabry's Disease (sequence of entire gene) [19]

Familial Combined Hyperlipidemia (main LPL mutation N291S) [20]

Familial Defective Apo B-100 (main mutation R3'500Q) [21]

Familial Defective Apo B-100 (sequence of binding site) [22]

Familial Dysbetalipoproteinemia (main plus additional mutations) [23]

Familial Dysbetalipoproteinemia (sequence of binding site) [24]

Familial Hypercholesterolemia (sequence of entire gene) [25]

Familial Hypercholesterolemia (sequencing of mutation in relatives if known) [26]

Familial Hypoalphalipoproteinemia (main mutations) [27]

Familial Hypoalphalipoproteinemia (sequence of entire gene) [28]

Familial Mediterrean Fever (main mutations) [29]

Familial Mediterrean Fever (sequence of exons 2, 3, 5) [30]

Glykogen Storage Disease, type 1, van Gierke (main mutations) [31]

Hypolactasia, adult type (main mutations) [32]

Tangier's Disease (main mutations) [33]

Wilson's Disease (main mutation H1069Q) [34]

Endocrinology

Multiple Endocrine Neoplasia 2A, 2B (sequence of exons 10, 11) [35]

Diabetology

Alström Disease (sequence of entire gene) [36]

Maturity Onset Diabetes of the Young, Type 2 [37]

Cardiology

ACE Inhibitor Efficacy (ACE, thrombophilia association marker) [38]

Alström Disease (sequence of entire gene) [39]

APC Resistance / Thrombophilia (F5, Leiden mutation) [40]

Atherosclerosis Association Marker (PTHR) [41]

Atherosclerosis Association Marker (SELP) [42]

Atherosclerosis Association Marker, hyperhomocysteinemia (MTHFR) [43]

Brugada Syndrome (sequence of entire gene) [44]

Fabry's Disease (main mutations) [45]

Fabry's Disease (sequence of entire gene) [46]

Familial Combined Hyperlipidemia (main LPL mutation N291S) [47]

Familial Defective Apo B-100 (main mutation R3'500Q) [48]

Familial Defective Apo B-100 (sequence of binding site) [49]

Familial Dysbetalipoproteinemia (main plus additional mutations) [50]

Familial Dysbetalipoproteinemia (sequence of binding site) [51]

Familial Hypercholesterolemia (sequence of entire gene) [52]

Familial Hypoalphalipoproteinemia (main mutations) [53]

Glanzmann Thrombasthenia (main mutation) [54]

Long QT Syndrome 1 (KVLQT1, main mutations) [55]

Long QT Syndrome 1 (KVLQT1, sequence of entire gene) [56]

Long QT Syndrome 2 (KCNH2, main mutations) [57]

Long QT Syndrome 2 (KCNH2, sequence of entire gene) [58]

Long QT Syndrome 3 (SCN5A, main mutations) [59]

Long QT Syndrome 3 (SCN5A, sequence of entire gene) [60]

Long QT Syndrome 5 (KCNE1, main mutations) [61]

Long QT Syndrome 5 (KCNE1, sequence of entire gene) [62]

Long QT Syndrome 6 (KCNE2, main mutations) [63]

Long QT Syndrome 6 (KCNE2, sequence of entire gene) [64]

Statin Drug Efficacy (SREBF2, drug side effects) [65]

Thrombophilia Association Marker IL4 [66]

Thrombophilia Association Marker PAI1 [67]

Angiology

Coumarine Efficacy (CAP2C9, drug side effects) [68]

Coumarine Efficacy (VKORC1, drug side effects) [69]

Gastroenterology

Familial Mediterrean Fever (main mutations) [70]

Familial Mediterrean Fever (sequence of exons 2, 3, 5) [71]

Hemochromatosis (H63D, C282Y, S65C, plus three additional mutations) [72]

Hemochromatosis (main mutations H63D, C282Y) [73]

Hemochromatosis (main mutations H63D, C282Y, S65C) [74]

Hypolactasia, adult type (main mutations) [75]

Wilson's Disease (main mutation H1069Q) [76]

Nephrology

ACE Inhibitor Efficacy (ACE inhibitors, drug side effects) [77]

Fabry's Disease (main mutations) [78]

Fabry's Disease (sequence of entire gene) [79]

Hematology

APC Resistance / Thrombophilia (F5, Leiden mutation) [80]

Glanzmann Thrombasthenia (main mutation) [81]

Hemochromatosis (H63D, C282Y, S65C, plus three additional mutations) [82]

Hemochromatosis (main mutations H63D, C282Y) [83]

Hemochromatosis (main mutations H63D, C282Y, S65C) [84]

Homocystinuria / Hyperhomocysteinemia (main mutation) [85]

Hyperprothrombinemia (PTH) [86]

Thrombophilia Association Marker IL4 [87]

Thrombophilia Association Marker PAI1 [88]

Thrombophilia Association Marker SELP [89]

Oncology

Li-Fraumeni Syndrome (sequence of exons 5,6,7) [90]

Multiple Endocrine Neoplasia 2A, 2B (sequence of exons 10. 11) [91]

Neurology

Alzheimer Dementia, sporadic association marker CST3 [92]

Alzheimer Dementia, sporadic association marker PS1 [93]

Alzheimer Dementia, sporadic association marker PS2 [94]

Alzheimer Dementia, sporadic, association marker A2M [95]

Alzheimer Dementia, sporadic, association marker ACE [96]

Alzheimer Dementia, sporadic, association marker APOE [97]

Alzheimer Dementia, sporadic, association marker APP [98]

Alzheimer Dementia, sporadic, association marker BCHE [99]

Alzheimer Dementia, sporadic, association marker CSTD [100]

Alzheimer Dementia, sporadic, association marker HFE [101]

Alzheimer Dementia, sporadic, association marker LPL [102]

Alzheimer Dementia, sporadic, association marker LRP [103]

Alzheimer Dementia, sporadic, association marker MPO [104]

CADASIL (sequence of promoter, exons 1-33) [105]

CADASIL (sequence of exons 2, 9, 10, 19, 20) [106]

CADASIL (sequence of exons 3, 4, 5, 6, 7, 8, 11) [107]

CADASIL (sequence of exons 3, 4; most frequent mutations) [108]

CADASIL (sequence of exons 5, 6, 7, 8, 11) [109]

Familial Alzheimer Dementia, early onset, Type 1 (APP) [110]

Familial Alzheimer Dementia, early onset, Type 3 (PS1) [111]

Familial Alzheimer Dementia, early onset, Type 4 (PS2) [112]

Frontotemporal Dementia, Pick disease (main mutation R370W) [113]

Frontotemporal Dementia, Pick disease (sequence of exons 9-13) [114]

Huntington Chorea [115]

Multiple Sclerosis, association marker DRB1 [116]

Infectiology

Antiretroviral Treatment (HAART) (SREBF1, drug side effects) [117]

Immunology

HLA DRB1 (sequence of exon 2) [118]

Interleukin 4 (IL4) [119]

Geriatry

Alzheimer Dementia, sporadic association marker CST3 [120]

Alzheimer Dementia, sporadic, association marker A2M [121]

Alzheimer Dementia, sporadic, association marker ACE [122]

Alzheimer Dementia, sporadic, association marker APOE [123]

Alzheimer Dementia, sporadic, association marker BCHE [124]

Alzheimer Dementia, sporadic, association marker CSTD [125]

Alzheimer Dementia, sporadic, association marker HFE [126]

Alzheimer Dementia, sporadic, association marker LPL [127]

Alzheimer Dementia, sporadic, association marker LRP [128]

Alzheimer Dementia, sporadic, association marker MPO [129]

Pharmacogenetics

Antiretroviral Treatment (HAART) (SREBF1, drug side effects) [130]

Efficacy of Alzheimer treatment, hyperlipidemia, and acne treatment, drug side effects (APOE) [131]

Efficacy of Coumarine-Derivatives (CYP 2C9, drug side effects) [132]

Efficacy of Coumarine-Derivatives (VKORC1, drug side effects) [133]

Efficacy of Hyperlipidemia Treatment (ACE inhibitors, drug side effects) [134]

Efficacy of Statins (LPL, drug side effects) [135]

Efficacy of Statins (SREBF2, drug side effects) [136]

Metabolism

Alström protein 1, ALMS1 (sequence of entire gene) [17]

Apolipoprotein A1 (main mutations) [27]

Apolipoprotein A1 (sequence of entire gene) [28]

Apolipoprotein B-100 (main mutation R3'500Q) [21]

Apolipoprotein B-100 (sequence of binding site) [22]

Apolipoprotein E (main plus additional mutations) [23]

Apolipoprotein E (sequence of binding site) [24]

ATP-binding casette 1 (main mutations) [33]

ATPase, Cu(2+)-transporting, beta polypeptide (main mutation H1069Q) [34]

Galactosidase, alpha (main mutations) [18]

Galactosidase, alpha (sequence of entire gene) [19]

Glucose-6-phosphatase (main mutations) [31]

Lactase Deficiency (main mutation in the promoter -13910, homozygous) [32]

Lipoprotein lipase (main mutation N291S) [20]

Low density lipoprotein receptor (sequence of entire gene) [25]

Low density lipoprotein receptor (sequencing of mutation in relatives if known) [26]

Pyrin (main mutations) [29]

Pyrin (sequence of exons 2, 3, 5) [30]

Endocrinology

RET transforming sequence (sequence of exons 10, 11) [35]

Diabetology

Alström protein 1, ALMS1 (sequence of entire gene) [36]

Glucokinase (sequence of entire gene) [37]

Cardiology

Alström protein 1, ALMS1 (sequence of entire gene) [39]

Angiotensin I converting enzyme (insertions/deletions polymorphism) [38]

Apolipoprotein B-100 (main mutation R3'500Q) [48]

Apolipoprotein B-100 (sequence of binding site) [49]

Apolipoprotein E (main plus additional mutations) [50]

Apolipoprotein E (sequence of binding site) [51]

ATP-binding casette 1 (main mutations) [53]

Coagulation factor II / prothrombin [41]

Coagulation factor V / proaccelerin (F5, Leiden mutation) [40]

Galactosidase, alpha (main mutations) [45]

Galactosidase, alpha (sequence of entire gene) [46]

Interleukin-4 (polymorphism) [66]

Lipoprotein lipase (main mutation N291S) [47]

Low density lipoprotein receptor (sequence of entire gene) [52]

Methylentetrahydrofolate reductase (mutation C677T) [43]

Plasminogen activator inhibitor 1 (insertions/deletions polymorphism) [67]

Platelet glycoprotein IIIa / Integrin, beta (mutation L33P) [54]

Potassium channel KCNE1 (main mutations) [61]

Potassium channel KCNE1 (sequence of entire gene) [62]

Potassium channel KCNE2 (main mutations) [63]

Potassium channel KCNE2 (sequence of entire gene) [64]

Potassium channel KCNH2 (main mutations) [57]

Potassium channel KCNH2 (sequence of entire gene) [58]

Potassium channel KVLQT1 (main mutations) [55]

Potassium channel KVLQT1 (sequence of entire gene) [56]

Selectin P (mutation V460L) [42]

Sodium channel, type V, SCN5A Brugada (sequence entire gene) [44]

Sodium channel, type V, SCN5A LQT (main mutations) [59]

Sodium channel, type V, SCN5A LQT (sequence entire gene) [60]

Sterol-regulatory element-binding protein-2 [65]

Angiology

Cytochrome P450, subfamily 2C, polypeptide 9 [68]

Vitamin K epoxide reductase complex, subunit 1 [69]

Gastroenterology

ATPase, Cu(2+)-transporting, beta polypeptide [76]

Hereditary hemochromatosis protein (main mutations H63D, C282Y) [73]

Hereditary hemochromatosis protein (main mutations H63D, C282Y, S65C) [74]

Hereditary hemochromatosis protein (main plus additional mutations) [72]

Lactase Deficiency (main mutation in the promoter -13910, homozygous) [75]

Pyrin (main mutations) [70]

Pyrin (sequence of exons 2, 3, 5) [71]

Nephrology

Angiotensin I converting enzyme (insertions/deletions polymorphism) [77]

Galactosidase, alpha (main mutations) [78]

Galactosidase, alpha (sequence of entire gene) [79]

Hematology

Coagulation factor II / prothrombin [86]

Coagulation factor V / proaccelerin (F5, Leiden mutation) [80]

Hereditary hemochromatosis protein (main mutations H63D, C282Y) [83]

Hereditary hemochromatosis protein (main mutations H63D, C282Y, S65C) [84]

Hereditary hemochromatosis protein (main plus additional mutations) [82]

Interleukin-4 (association marker) [87]

Methylentetrahydrofolate reductase (mutation C677T) [85]

Plasminogen activator inhibitor 1 (insertions/deletions polymorphism) [88]

Platelet glycoprotein IIIa / Integrin, beta (mutation L33P) [81]

Selectin P (mutation V460L) [89]

Oncology

RET transforming sequence [91]

Tumor protein p53 [90]

Neurology

Alpha-2 macroglobulin [95]

Amyloid beta (A4) precursor protein (association marker) [98]

Amyloid beta (A4) precursor protein (mutation E693Q) [110]

Angiotensin I converting enzyme (insertions/deletions polymorphism) [96]

Apolipoprotein E (main plus additional mutations) [97]

Butyrylcholinesterase (association marker) [99]

Cathepsin D (lysosomal aspartyl protease) [100]

Cystatin C (association marker) [92]

Hereditary hemochromatosis protein (main mutations H63D, C282Y) [101]

Huntingtin (triplett-repeat expansion) [115]

Lipoprotein lipase (association marker) [102]

Low density lipoprotein receptor-related protein-1 (alpha-2-Macroglobulin Receptor) (association marker) [103]

Major histocompatibility complex, class II, DR beta-1 (association marker) [116]

Microtubule-associated protein tau (main mutation R370W) [113]

Microtubule-associated protein tau (sequence of exons 9-13) [114]

Myeloperoxidase (association marker) [104]

NOTCH3 (sequence of promoter, exons 1-23) [105]

NOTCH3 (sequence of exons 2, 9, 10, 19, 20) [106]

NOTCH3 (sequence of exons 3, 4, 5, 6, 7, 8, 11) [107]

NOTCH3 (sequence of exons 3, 4; most frequent mutations) [108]

NOTCH3 (sequence of exons 5, 6, 7, 8, 11) [109]

Presenilin 1 (association marker) [93]

Presenilin 1 (main mutations) [111]

Presenilin 2 (association marker) [94]

Presenilin 2 (main mutations) [112]

Infectiology

Sterol-regulatory element-binding protein-1c [117]

Immunology

Interleukin-4 (association marker) [119]

Major histocompatibility complex, class II, DR beta-1 [118]

Geriatry

Alpha-2 macroglobulin (association marker) [121]

Angiotensin I converting enzyme (association marker) [122]

Apolipoprotein E (association marker) [123]

Butyrylcholinesterase (association marker) [124]

Cathepsin D (lysosomal aspartyl protease) (association marker) [125]

Cystatin C (association marker) [120]

Hereditary hemochromatosis protein (association marker) [126]

Lipoprotein lipase (association marker) [127]

Low density lipoprotein receptor-related protein-1 (alpha-2-Macroglobulin Receptor) (association marker) [128]

Myeloperoxidase (association marker) [129]

Pharmacogenetics

Angiotensin I converting enzyme [134]

Apolipoprotein E [131]

Cytochrome P450, subfamily 2C, polypeptide 9 [132]

Lipoprotein lipase [135]

Sterol-regulatory element-binding Protein-1c [130]

Sterol-regulatory element-binding Protein-2 [136]

Vitamin K epoxide reductase complex, subunit 1 [133]

Source URL (retrieved on 02/23/2012 - 00:00): http://www.diagene.ch/research/services

Links:
[1] http://www.diagene.ch/print/research/services?quicktabs_1=0#quicktabs-1
[2] http://www.diagene.ch/print/research/services?quicktabs_1=1#quicktabs-1
[3] http://www.diagene.ch/print/research/services?quicktabs_1000=0#quicktabs-1000
[4] http://www.diagene.ch/print/research/services?quicktabs_1000=1#quicktabs-1000
[5] http://www.diagene.ch/print/research/services?quicktabs_1000=2#quicktabs-1000
[6] http://www.diagene.ch/print/research/services?quicktabs_1000=3#quicktabs-1000
[7] http://www.diagene.ch/print/research/services?quicktabs_1000=4#quicktabs-1000
[8] http://www.diagene.ch/print/research/services?quicktabs_1000=5#quicktabs-1000
[9] http://www.diagene.ch/print/research/services?quicktabs_1000=6#quicktabs-1000
[10] http://www.diagene.ch/print/research/services?quicktabs_1000=7#quicktabs-1000
[11] http://www.diagene.ch/print/research/services?quicktabs_1000=8#quicktabs-1000
[12] http://www.diagene.ch/print/research/services?quicktabs_1000=9#quicktabs-1000
[13] http://www.diagene.ch/print/research/services?quicktabs_1000=10#quicktabs-1000
[14] http://www.diagene.ch/print/research/services?quicktabs_1000=11#quicktabs-1000
[15] http://www.diagene.ch/print/research/services?quicktabs_1000=12#quicktabs-1000
[16] http://www.diagene.ch/print/research/services?quicktabs_1000=13#quicktabs-1000
[17] http://www.diagene.ch/services/gene-tests/01-001-alstroem-disease-sequence-entire-gene
[18] http://www.diagene.ch/services/gene-tests/01-002-fabrys-disease-main-mutations
[19] http://www.diagene.ch/services/gene-tests/01-002-fabrys-disease-sequence-entire-gene
[20] http://www.diagene.ch/services/gene-tests/01-003-familial-combined-hyperlipidemia-main-lpl-mutation-n291s
[21] http://www.diagene.ch/services/gene-tests/01-004-familial-defective-apo-b-100-main-mutation-r3500q
[22] http://www.diagene.ch/services/gene-tests/01-005-familial-defective-apo-b-100-sequence-binding-site
[23] http://www.diagene.ch/services/gene-tests/01-006-familial-dysbetalipoproteinemia-main-plus-additional-mutations
[24] http://www.diagene.ch/services/gene-tests/01-007-familial-dysbetalipoproteinemia-sequence-binding-site
[25] http://www.diagene.ch/services/gene-tests/01-008-familial-hypercholesterolemia-sequence-entire-gene
[26] http://www.diagene.ch/services/gene-tests/01-009-familial-hypercholesterolemia-sequencing-mutation-relatives-if-known
[27] http://www.diagene.ch/services/gene-tests/01-010-familial-hypoalphalipoproteinemia-main-mutations
[28] http://www.diagene.ch/services/gene-tests/01-011-familial-hypoalphalipoproteinemia-sequence-entire-gene
[29] http://www.diagene.ch/services/gene-tests/01-012-familial-mediterrean-fever-main-mutations
[30] http://www.diagene.ch/services/gene-tests/01-013-familial-mediterrean-fever-sequence-exons-2-3-5
[31] http://www.diagene.ch/services/gene-tests/01-014-glykogen-storage-disease-type-1-van-gierke-main-mutations
[32] http://www.diagene.ch/services/gene-tests/01-017-hypolactasia-adult-type-main-mutations
[33] http://www.diagene.ch/services/gene-tests/01-015-tangiers-disease-main-mutations
[34] http://www.diagene.ch/services/gene-tests/01-016-wilsons-disease-main-mutation-h1069q
[35] http://www.diagene.ch/services/gene-tests/02-001-multiple-endocrine-neoplasia-2a-2b-sequence-exons-10-11
[36] http://www.diagene.ch/services/gene-tests/03-001-alstroem-disease-sequence-entire-gene
[37] http://www.diagene.ch/services/gene-tests/03-002-maturity-onset-diabetes-young-type-2
[38] http://www.diagene.ch/services/gene-tests/04-002-ace-inhibitor-efficacy-ace-thrombophilia-association-marker
[39] http://www.diagene.ch/services/gene-tests/04-001-alstroem-disease-sequence-entire-gene
[40] http://www.diagene.ch/services/gene-tests/04-003-apc-resistance-thrombophilia-f5-leiden-mutation
[41] http://www.diagene.ch/services/gene-tests/04-005-atherosclerosis-association-marker-pthr
[42] http://www.diagene.ch/services/gene-tests/04-006-atherosclerosis-association-marker-selp
[43] http://www.diagene.ch/services/gene-tests/04-004-atherosclerosis-association-marker-hyperhomocysteinemia-mthfr
[44] http://www.diagene.ch/services/gene-tests/04-007-brugada-syndrome-sequence-entire-gene
[45] http://www.diagene.ch/services/gene-tests/04-008-fabrys-disease-main-mutations
[46] http://www.diagene.ch/services/gene-tests/04-009-fabrys-disease-sequence-entire-gene
[47] http://www.diagene.ch/services/gene-tests/04-010-familial-combined-hyperlipidemia-main-lpl-mutation-n291s
[48] http://www.diagene.ch/services/gene-tests/04-011-familial-defective-apo-b-100-main-mutation-r3500q
[49] http://www.diagene.ch/services/gene-tests/04-012-familial-defective-apo-b-100-sequence-binding-site
[50] http://www.diagene.ch/services/gene-tests/04-013-familial-dysbetalipoproteinemia-main-plus-additional-mutations
[51] http://www.diagene.ch/services/gene-tests/04-014-familial-dysbetalipoproteinemia-sequence-binding-site
[52] http://www.diagene.ch/services/gene-tests/04-015-familial-hypercholesterolemia-sequence-entire-gene
[53] http://www.diagene.ch/services/gene-tests/04-016-familial-hypoalphalipoproteinemia-main-mutations
[54] http://www.diagene.ch/services/gene-tests/04-017-glanzmann-thrombasthenia-main-mutation
[55] http://www.diagene.ch/services/gene-tests/04-018-long-qt-syndrome-1-kvlqt1-main-mutations
[56] http://www.diagene.ch/services/gene-tests/04-019-long-qt-syndrome-1-kvlqt1-sequence-entire-gene
[57] http://www.diagene.ch/services/gene-tests/04-020-long-qt-syndrome-2-kcnh2-main-mutations
[58] http://www.diagene.ch/services/gene-tests/04-021-long-qt-syndrome-2-kcnh2-sequence-entire-gene
[59] http://www.diagene.ch/services/gene-tests/04-022-long-qt-syndrome-3-scn5a-main-mutations
[60] http://www.diagene.ch/services/gene-tests/04-023-long-qt-syndrome-3-scn5a-sequence-entire-gene
[61] http://www.diagene.ch/services/gene-tests/04-024-long-qt-syndrome-5-kcne1-main-mutations
[62] http://www.diagene.ch/services/gene-tests/04-025-long-qt-syndrome-5-kcne1-sequence-entire-gene
[63] http://www.diagene.ch/services/gene-tests/04-026-long-qt-syndrome-6-kcne2-main-mutations
[64] http://www.diagene.ch/services/gene-tests/04-027-long-qt-syndrome-6-kcne2-sequence-entire-gene
[65] http://www.diagene.ch/services/gene-tests/04-028-statin-drug-efficacy-srebf2-drug-side-effects
[66] http://www.diagene.ch/services/gene-tests/04-029-thrombophilia-association-marker-il4
[67] http://www.diagene.ch/services/gene-tests/04-030-thrombophilia-association-marker-pai1
[68] http://www.diagene.ch/services/gene-tests/05-001-coumarine-efficacy-cap2c9-drug-side-effects
[69] http://www.diagene.ch/services/gene-tests/05-002-coumarine-efficacy-vkorc1-drug-side-effects
[70] http://www.diagene.ch/services/gene-tests/06-001-familial-mediterrean-fever-main-mutations
[71] http://www.diagene.ch/services/gene-tests/06-002-familial-mediterrean-fever-sequence-exons-2-3-5
[72] http://www.diagene.ch/services/gene-tests/06-005-hemochromatosis-h63d-c282y-s65c-plus-three-additional-mutations
[73] http://www.diagene.ch/services/gene-tests/06-003-hemochromatosis-main-mutations-h63d-c282y
[74] http://www.diagene.ch/services/gene-tests/06-004-hemochromatosis-main-mutations-h63d-c282y-s65c
[75] http://www.diagene.ch/services/gene-tests/06-006-hypolactasia-adult-type-main-mutations
[76] http://www.diagene.ch/services/gene-tests/06-007-wilsons-disease-main-mutation-h1069q
[77] http://www.diagene.ch/services/gene-tests/07-001-ace-inhibitor-efficacy-ace-inhibitors-drug-side-effects
[78] http://www.diagene.ch/services/gene-tests/07-002-fabrys-disease-main-mutations
[79] http://www.diagene.ch/services/gene-tests/07-003-fabrys-disease-sequence-entire-gene
[80] http://www.diagene.ch/services/gene-tests/08-001-apc-resistance-thrombophilia-f5-leiden-mutation
[81] http://www.diagene.ch/services/gene-tests/08-002-glanzmann-thrombasthenia-main-mutation
[82] http://www.diagene.ch/services/gene-tests/08-005-hemochromatosis-h63d-c282y-s65c-plus-three-additional-mutations
[83] http://www.diagene.ch/services/gene-tests/08-003-hemochromatosis-main-mutations-h63d-c282y
[84] http://www.diagene.ch/services/gene-tests/08-004-hemochromatosis-main-mutations-h63d-c282y-s65c
[85] http://www.diagene.ch/services/gene-tests/08-006-homocystinuria-hyperhomocysteinemia-main-mutation
[86] http://www.diagene.ch/services/gene-tests/08-007-hyperprothrombinemia-pth
[87] http://www.diagene.ch/services/gene-tests/08-008-thrombophilia-association-marker-il4
[88] http://www.diagene.ch/services/gene-tests/08-009-thrombophilia-association-marker-pai1
[89] http://www.diagene.ch/services/gene-tests/08-010-thrombophilia-association-marker-selp
[90] http://www.diagene.ch/services/gene-tests/09-001-li-fraumeni-syndrome-sequence-exons-567
[91] http://www.diagene.ch/services/gene-tests/09-002-multiple-endocrine-neoplasia-2a-2b-sequence-exons-10-11
[92] http://www.diagene.ch/services/gene-tests/10-001-alzheimer-dementia-sporadic-association-marker-cst3
[93] http://www.diagene.ch/services/gene-tests/10-002-alzheimer-dementia-sporadic-association-marker-ps1
[94] http://www.diagene.ch/services/gene-tests/10-003-alzheimer-dementia-sporadic-association-marker-ps2
[95] http://www.diagene.ch/services/gene-tests/10-004-alzheimer-dementia-sporadic-association-marker-a2m
[96] http://www.diagene.ch/services/gene-tests/10-005-alzheimer-dementia-sporadic-association-marker-ace
[97] http://www.diagene.ch/services/gene-tests/10-006-alzheimer-dementia-sporadic-association-marker-apoe
[98] http://www.diagene.ch/services/gene-tests/10-007-alzheimer-dementia-sporadic-association-marker-app
[99] http://www.diagene.ch/services/gene-tests/10-008-alzheimer-dementia-sporadic-association-marker-bche
[100] http://www.diagene.ch/services/gene-tests/10-009-alzheimer-dementia-sporadic-association-marker-cstd
[101] http://www.diagene.ch/services/gene-tests/10-010-alzheimer-dementia-sporadic-association-marker-hfe
[102] http://www.diagene.ch/services/gene-tests/10-011-alzheimer-dementia-sporadic-association-marker-lpl
[103] http://www.diagene.ch/services/gene-tests/10-012-alzheimer-dementia-sporadic-association-marker-lrp
[104] http://www.diagene.ch/services/gene-tests/10-013-alzheimer-dementia-sporadic-association-marker-mpo
[105] http://www.diagene.ch/services/gene-tests/10-018-cadasil-sequence-promoter-exons-1-33
[106] http://www.diagene.ch/services/gene-tests/10-017-cadasil-sequence-exons-2-9-10-19-20
[107] http://www.diagene.ch/services/gene-tests/10-016-cadasil-sequence-exons-3-4-5-6-7-8-11
[108] http://www.diagene.ch/services/gene-tests/10-014-cadasil-sequence-exons-3-4-most-frequent-mutations
[109] http://www.diagene.ch/services/gene-tests/10-015-cadasil-sequence-exons-5-6-7-8-11
[110] http://www.diagene.ch/services/gene-tests/10-019-familial-alzheimer-dementia-early-onset-type-1-app
[111] http://www.diagene.ch/services/gene-tests/10-020-familial-alzheimer-dementia-early-onset-type-3-ps1
[112] http://www.diagene.ch/services/gene-tests/10-021-familial-alzheimer-dementia-early-onset-type-4-ps2
[113] http://www.diagene.ch/services/gene-tests/10-022-frontotemporal-dementia-pick-disease-main-mutation-r370w
[114] http://www.diagene.ch/services/gene-tests/10-023-frontotemporal-dementia-pick-disease-sequence-exons-9-13
[115] http://www.diagene.ch/services/gene-tests/10-024-huntington-chorea
[116] http://www.diagene.ch/services/gene-tests/10-025-multiple-sclerosis-association-marker-drb1
[117] http://www.diagene.ch/services/gene-tests/11-001-antiretroviral-treatment-haart-srebf1-drug-side-effects
[118] http://www.diagene.ch/services/gene-tests/12-001-hla-drb1-sequence-exon-2
[119] http://www.diagene.ch/services/gene-tests/12-002-interleukin-4-il4
[120] http://www.diagene.ch/services/gene-tests/13-001-alzheimer-dementia-sporadic-association-marker-cst3
[121] http://www.diagene.ch/services/gene-tests/13-002-alzheimer-dementia-sporadic-association-marker-a2m
[122] http://www.diagene.ch/services/gene-tests/13-003-alzheimer-dementia-sporadic-association-marker-ace
[123] http://www.diagene.ch/services/gene-tests/13-004-alzheimer-dementia-sporadic-association-marker-apoe
[124] http://www.diagene.ch/services/gene-tests/13-005-alzheimer-dementia-sporadic-association-marker-bche
[125] http://www.diagene.ch/services/gene-tests/13-006-alzheimer-dementia-sporadic-association-marker-cstd
[126] http://www.diagene.ch/services/gene-tests/13-007-alzheimer-dementia-sporadic-association-marker-hfe
[127] http://www.diagene.ch/services/gene-tests/13-008-alzheimer-dementia-sporadic-association-marker-lpl
[128] http://www.diagene.ch/services/gene-tests/13-009-alzheimer-dementia-sporadic-association-marker-lrp
[129] http://www.diagene.ch/services/gene-tests/13-010-alzheimer-dementia-sporadic-association-marker-mpo
[130] http://www.diagene.ch/services/gene-tests/14-1-antiretroviral-treatment-haart-srebf1-drug-side-effects
[131] http://www.diagene.ch/services/gene-tests/14-002-efficacy-alzheimer-treatment-hyperlipidemia-and-acne-treatment-drug-side-
[132] http://www.diagene.ch/services/gene-tests/14-003-efficacy-coumarine-derivatives-cyp-2c9-drug-side-effects
[133] http://www.diagene.ch/services/gene-tests/14-004-efficacy-coumarine-derivatives-vkorc1-drug-side-effects
[134] http://www.diagene.ch/services/gene-tests/14-005-efficacy-hyperlipidemia-treatment-ace-inhibitors-drug-side-effects
[135] http://www.diagene.ch/services/gene-tests/14-006-efficacy-statins-lpl-drug-side-effects
[136] http://www.diagene.ch/services/gene-tests/14-007-efficacy-statins-srebf2-drug-side-effects
[137] http://www.diagene.ch/print/research/services?quicktabs_1001=0#quicktabs-1001
[138] http://www.diagene.ch/print/research/services?quicktabs_1001=1#quicktabs-1001
[139] http://www.diagene.ch/print/research/services?quicktabs_1001=2#quicktabs-1001
[140] http://www.diagene.ch/print/research/services?quicktabs_1001=3#quicktabs-1001
[141] http://www.diagene.ch/print/research/services?quicktabs_1001=4#quicktabs-1001
[142] http://www.diagene.ch/print/research/services?quicktabs_1001=5#quicktabs-1001
[143] http://www.diagene.ch/print/research/services?quicktabs_1001=6#quicktabs-1001
[144] http://www.diagene.ch/print/research/services?quicktabs_1001=7#quicktabs-1001
[145] http://www.diagene.ch/print/research/services?quicktabs_1001=8#quicktabs-1001
[146] http://www.diagene.ch/print/research/services?quicktabs_1001=9#quicktabs-1001
[147] http://www.diagene.ch/print/research/services?quicktabs_1001=10#quicktabs-1001
[148] http://www.diagene.ch/print/research/services?quicktabs_1001=11#quicktabs-1001
[149] http://www.diagene.ch/print/research/services?quicktabs_1001=12#quicktabs-1001
[150] http://www.diagene.ch/print/research/services?quicktabs_1001=13#quicktabs-1001